Monogram Technologies Inc. (MGRM)
NASDAQ: MGRM · Real-Time Price · USD
2.580
+0.070 (2.79%)
At close: Dec 20, 2024, 4:00 PM
2.500
-0.080 (-3.10%)
After-hours: Dec 20, 2024, 5:19 PM EST
Company Description
Monogram Technologies Inc. focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants.
The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures.
Its robot prototype executes optimized paths for high-precision insertion of optimized implants in synthetic bone specimens.
The company was formerly known as Monogram Orthopaedics, Inc. and changed its name to Monogram Technologies Inc. in May 2024.
Monogram Technologies Inc. was founded in 2015 and is headquartered in Austin, Texas.
Monogram Technologies Inc.
| Country | United States |
| Founded | 2016 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 28 |
| CEO | Benjamin Sexson |
Contact Details
Address: 3913 Todd Lane, Suite 307 Austin, Texas 78744 United States | |
| Phone | 512 399 2656 |
| Website | monogramorthopedics.com |
Stock Details
| Ticker Symbol | MGRM |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001769759 |
| CUSIP Number | 609786108 |
| ISIN Number | US6097861081 |
| Employer ID | 81-2349540 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Benjamin Sexson C.F.A. | Chairman of the Board, President and Chief Executive Officer |
| Dr. Douglas Unis | Founder, Chief Medical Officer and Director |
| Noel Knape C.P.A., M.B.A. | Chief Financial Officer |
| Dr. Kamran Shamaei Ph.D. | Chief Technology Officer |
| Chris Tyson | Executive Vice President - MZ North America |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 18, 2024 | 8-K | Current Report |
| Dec 2, 2024 | 8-K | Current Report |
| Nov 14, 2024 | 10-Q | Quarterly Report |
| Nov 14, 2024 | 8-K | Current Report |
| Nov 8, 2024 | DEF 14A | Other definitive proxy statements |
| Oct 30, 2024 | PRE 14A | Other preliminary proxy statements |
| Oct 29, 2024 | 8-K | Current Report |
| Oct 3, 2024 | 8-K | Current Report |
| Oct 2, 2024 | 424B5 | Filing |
| Oct 2, 2024 | 8-K | Current Report |